AFP and hepatocellular carcinoma: However, even though cirrhotic patients are monitored for early detection of HCC with ultrasound and/or alfa-fetoprotein (AFP) levels, many of them show advanced disease at diagnosis [11] or reach this stage after progression to local therapies.